Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration Stable (no update expected for reasons given in 'What's new')
Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration Stable (no update expected for reasons given in 'What's new') is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Antiangiogenic Therapy With Interferon Alfa for Neovascular Age‐related Macular Degeneration Stable (no Update Expected for Reasons Given in 'What's New')." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433522/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age‐related_macular_degeneration_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed 23 January 2021.
Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration Stable (no update expected for reasons given in 'What's new'). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433522/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age‐related_macular_degeneration_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed January 23, 2021.
Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration Stable (no update expected for reasons given in 'What's new'). In Cochrane Abstracts Retrieved January 23, 2021, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/433522/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age‐related_macular_degeneration_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
Antiangiogenic Therapy With Interferon Alfa for Neovascular Age‐related Macular Degeneration Stable (no Update Expected for Reasons Given in 'What's New') [Internet]. In: Cochrane Abstracts. [cited 2021 January 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433522/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age‐related_macular_degeneration_Stable__no_update_expected_for_reasons_given_in_'What's_new'_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration Stable (no update expected for reasons given in 'What's new')
ID - 433522
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433522/all/Antiangiogenic_therapy_with_interferon_alfa_for_neovascular_age‐related_macular_degeneration_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
DB - Evidence Central
DP - Unbound Medicine
ER -